663 related articles for article (PubMed ID: 19762341)
1. Bone morphogenetic protein receptors and signal transduction.
Miyazono K; Kamiya Y; Morikawa M
J Biochem; 2010 Jan; 147(1):35-51. PubMed ID: 19762341
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
3. Bone Morphogenetic Proteins.
Katagiri T; Watabe T
Cold Spring Harb Perspect Biol; 2016 Jun; 8(6):. PubMed ID: 27252362
[TBL] [Abstract][Full Text] [Related]
4. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into BMP receptors: Specificity, activation and inhibition.
Yadin D; Knaus P; Mueller TD
Cytokine Growth Factor Rev; 2016 Feb; 27():13-34. PubMed ID: 26690041
[TBL] [Abstract][Full Text] [Related]
6. BMP signaling in vascular diseases.
Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
[TBL] [Abstract][Full Text] [Related]
7. The bone morphogenetic protein system and the regulation of ovarian follicle development in mammals.
Rossi RO; Costa JJ; Silva AW; Saraiva MV; Van den Hurk R; Silva JR
Zygote; 2016 Feb; 24(1):1-17. PubMed ID: 25613521
[TBL] [Abstract][Full Text] [Related]
8. Secreted BMP antagonists and their role in cancer and bone metastases.
Todd GM; Gao Z; Hyvönen M; Brazil DP; Ten Dijke P
Bone; 2020 Aug; 137():115455. PubMed ID: 32473315
[TBL] [Abstract][Full Text] [Related]
9. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.
Miyazono K; Maeda S; Imamura T
Cytokine Growth Factor Rev; 2005 Jun; 16(3):251-63. PubMed ID: 15871923
[TBL] [Abstract][Full Text] [Related]
10. Divergence and convergence of TGF-beta/BMP signaling.
Miyazono K; Kusanagi K; Inoue H
J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
[TBL] [Abstract][Full Text] [Related]
11. Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells.
Boergermann JH; Kopf J; Yu PB; Knaus P
Int J Biochem Cell Biol; 2010 Nov; 42(11):1802-7. PubMed ID: 20691279
[TBL] [Abstract][Full Text] [Related]
12. Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity.
Alsamarah A; LaCuran AE; Oelschlaeger P; Hao J; Luo Y
PLoS One; 2015; 10(7):e0132221. PubMed ID: 26133550
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.
Cuny GD; Yu PB; Laha JK; Xing X; Liu JF; Lai CS; Deng DY; Sachidanandan C; Bloch KD; Peterson RT
Bioorg Med Chem Lett; 2008 Aug; 18(15):4388-92. PubMed ID: 18621530
[TBL] [Abstract][Full Text] [Related]
14. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
[TBL] [Abstract][Full Text] [Related]
15. [Bone morphogenetic protein (BMP) receptors and signal transduction].
Yamashita H; Miyazono K
Nihon Rinsho; 1999 Jan; 57(1):220-6. PubMed ID: 10036966
[TBL] [Abstract][Full Text] [Related]
16. Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro.
Yamasaki A; Kasai A; Toi A; Kurita M; Kimoto S; Hayata-Takano A; Nakazawa T; Nagayasu K; Shintani N; Hashimoto R; Ito A; Meltzer HY; Ago Y; Waschek JA; Onaka Y; Matsuda T; Baba A; Hashimoto H
J Neurochem; 2015 Feb; 132(4):418-28. PubMed ID: 25421849
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
Jiramongkolchai P; Owens P; Hong CC
Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
[TBL] [Abstract][Full Text] [Related]
18. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.
Gilboa L; Nohe A; Geissendörfer T; Sebald W; Henis YI; Knaus P
Mol Biol Cell; 2000 Mar; 11(3):1023-35. PubMed ID: 10712517
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein signal transduction in bone.
ten Dijke P
Curr Med Res Opin; 2006; 22 Suppl 1():S7-11. PubMed ID: 16882364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
